APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tasimelteon

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Tasimelteon Market Outlook and Growth Opportunities 2026

2 January 2026193 pages

Choose your research edition.

Industry ResearchTasimelteon Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Tasimelteon Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Tasimelteon Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tasimelteon Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Tasimelteon Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Tasimelteon market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Tasimelteon is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tasimelteon is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tasimelteon is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Tasimelteon market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Tasimelteon market include Vanda Pharmaceuticals and Teva Pharmaceuticals among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Tasimelteon market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tasimelteon and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tasimelteon sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tasimelteon market size, projected growth trends, production technologies, key applications, and end-use industries.

Tasimelteon Segment by Company

Vanda Pharmaceuticals

Teva Pharmaceuticals

Tasimelteon Segment by Type

Original Drug

Generic Drug

Tasimelteon Segment by Application

Hospital

Clinic

Other

Tasimelteon Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Tasimelteon status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Tasimelteon market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Tasimelteon significant trends, drivers, influence factors in global and regions.

6. To analyze Tasimelteon competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tasimelteon market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tasimelteon and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tasimelteon.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Tasimelteon market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tasimelteon industry.

Chapter 3: Detailed analysis of Tasimelteon manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Tasimelteon in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Tasimelteon in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Tasimelteon Industry Trends Table 2. Tasimelteon Industry Drivers Table 3. Tasimelteon Industry Opportunities and Challenges Table 4. Tasimelteon Industry Restraints Table 5. Global Tasimelteon Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Tasimelteon Revenue Share by Company (2021-2026) Table 7. Global Tasimelteon Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Tasimelteon Sales Volume Share by Company (2021-2026) Table 9. Global Tasimelteon Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Tasimelteon Company Ranking, (2024-2026) & (USD Million) Table 11. Global Tasimelteon Key Company Manufacturing Base & Headquarters Table 12. Global Tasimelteon Company, Product Type & Application Table 13. Global Tasimelteon Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Tasimelteon by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Original Drug Table 18. Significant Companies of Generic Drug Table 19. Global Tasimelteon Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Tasimelteon Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Tasimelteon Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Tasimelteon Sales Volume Share by Type (2021-2026) Table 23. Global Tasimelteon Sales Volume Share by Type (2027-2032) Table 24. Global Tasimelteon Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Tasimelteon Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Tasimelteon Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Tasimelteon Sales Value Share by Type (2021-2026) Table 28. Global Tasimelteon Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Other Table 32. Global Tasimelteon Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Tasimelteon Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Tasimelteon Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Tasimelteon Sales Volume Share by Application (2021-2026) Table 36. Global Tasimelteon Sales Volume Share by Application (2027-2032) Table 37. Global Tasimelteon Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Tasimelteon Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Tasimelteon Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Tasimelteon Sales Value Share by Application (2021-2026) Table 41. Global Tasimelteon Sales Value Share by Application (2027-2032) Table 42. Global Tasimelteon Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Tasimelteon Sales by Region (2021-2026) & (K Units) Table 44. Global Tasimelteon Sales Market Share by Region (2021-2026) Table 45. Global Tasimelteon Sales by Region (2027-2032) & (K Units) Table 46. Global Tasimelteon Sales Market Share by Region (2027-2032) Table 47. Global Tasimelteon Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Tasimelteon Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Tasimelteon Sales Value Share by Region (2021-2026) Table 50. Global Tasimelteon Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Tasimelteon Sales Value Share by Region (2027-2032) Table 52. Global Tasimelteon Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Tasimelteon Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Tasimelteon Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Tasimelteon Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Tasimelteon Sales by Country (2021-2026) & (K Units) Table 57. Global Tasimelteon Sales Market Share by Country (2021-2026) Table 58. Global Tasimelteon Sales by Country (2027-2032) & (K Units) Table 59. Global Tasimelteon Sales Market Share by Country (2027-2032) Table 60. Global Tasimelteon Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Tasimelteon Sales Value Market Share by Country (2021-2026) Table 62. Global Tasimelteon Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Tasimelteon Sales Value Market Share by Country (2027-2032) Table 64. Vanda Pharmaceuticals Company Information Table 65. Vanda Pharmaceuticals Business Overview Table 66. Vanda Pharmaceuticals Tasimelteon Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Vanda Pharmaceuticals Tasimelteon Product Portfolio Table 68. Vanda Pharmaceuticals Recent Development Table 69. Teva Pharmaceuticals Company Information Table 70. Teva Pharmaceuticals Business Overview Table 71. Teva Pharmaceuticals Tasimelteon Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Teva Pharmaceuticals Tasimelteon Product Portfolio Table 73. Teva Pharmaceuticals Recent Development Table 74. Key Raw Materials Table 75. Raw Materials Key Suppliers Table 76. Tasimelteon Distributors List Table 77. Tasimelteon Customers List Table 78. Research Programs/Design for This Report Table 79. Authors List of This Report Table 80. Secondary Sources Table 81. Primary Sources List of Figures Figure 1. Tasimelteon Product Image Figure 2. Global Tasimelteon Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tasimelteon Sales Value (2021-2032) & (US$ Million) Figure 4. Global Tasimelteon Sales (2021-2032) & (K Units) Figure 5. Global Tasimelteon Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Tasimelteon Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Original Drug Image Figure 10. Generic Drug Image Figure 11. Global Tasimelteon Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Tasimelteon Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Tasimelteon Sales Volume Share by Type (2021-2032) Figure 14. Global Tasimelteon Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Tasimelteon Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Tasimelteon Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Tasimelteon Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Tasimelteon Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Tasimelteon Sales Volume Share by Application (2021-2032) Figure 23. Global Tasimelteon Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Tasimelteon Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Tasimelteon Sales Value Share by Application (2021-2032) Figure 26. Global Tasimelteon Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Tasimelteon Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Tasimelteon Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Tasimelteon Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Tasimelteon Sales Value (2021-2032) & (US$ Million) Figure 31. North America Tasimelteon Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Tasimelteon Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Tasimelteon Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Tasimelteon Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Tasimelteon Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Tasimelteon Sales Value (2021-2032) & (US$ Million) Figure 37. South America Tasimelteon Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Tasimelteon Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Tasimelteon Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Tasimelteon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Tasimelteon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Tasimelteon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Tasimelteon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Tasimelteon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Tasimelteon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Tasimelteon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Tasimelteon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Tasimelteon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Tasimelteon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Tasimelteon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Tasimelteon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Tasimelteon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Tasimelteon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Tasimelteon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Tasimelteon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Tasimelteon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Tasimelteon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Tasimelteon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Tasimelteon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Tasimelteon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Tasimelteon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Tasimelteon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Tasimelteon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Tasimelteon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Tasimelteon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Tasimelteon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Tasimelteon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Tasimelteon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Tasimelteon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Tasimelteon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Tasimelteon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Tasimelteon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Tasimelteon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Tasimelteon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Tasimelteon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Tasimelteon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Tasimelteon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Tasimelteon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Tasimelteon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Tasimelteon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Tasimelteon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Tasimelteon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Tasimelteon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Tasimelteon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Tasimelteon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Tasimelteon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Tasimelteon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Tasimelteon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Tasimelteon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Tasimelteon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Tasimelteon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Tasimelteon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Tasimelteon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Tasimelteon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Tasimelteon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Tasimelteon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Tasimelteon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Tasimelteon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Tasimelteon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Tasimelteon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Tasimelteon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Tasimelteon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Tasimelteon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Tasimelteon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Tasimelteon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Tasimelteon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Tasimelteon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Tasimelteon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Tasimelteon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Tasimelteon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Tasimelteon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Tasimelteon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Tasimelteon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Tasimelteon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Tasimelteon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Tasimelteon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Tasimelteon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Tasimelteon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Tasimelteon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Tasimelteon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Tasimelteon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Tasimelteon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Tasimelteon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Tasimelteon Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Tasimelteon Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Vanda Pharmaceuticals
  • Teva Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tasimelteon Sales Value (2021-2032)
  4. 1.2.2 Global Tasimelteon Sales Volume (2021-2032)
  5. 1.2.3 Global Tasimelteon Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Tasimelteon Market Dynamics
  1. 2.1 Tasimelteon Industry Trends
  2. 2.2 Tasimelteon Industry Drivers
  3. 2.3 Tasimelteon Industry Opportunities and Challenges
  4. 2.4 Tasimelteon Industry Restraints
3 Tasimelteon Market by Company
  1. 3.1 Global Tasimelteon Company Revenue Ranking in 2025
  2. 3.2 Global Tasimelteon Revenue by Company (2021-2026)
  3. 3.3 Global Tasimelteon Sales Volume by Company (2021-2026)
  4. 3.4 Global Tasimelteon Average Price by Company (2021-2026)
  5. 3.5 Global Tasimelteon Company Ranking (2024-2026)
  6. 3.6 Global Tasimelteon Company Manufacturing Base and Headquarters
  7. 3.7 Global Tasimelteon Company Product Type and Application
  8. 3.8 Global Tasimelteon Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Tasimelteon Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Tasimelteon Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Tasimelteon Market by Type
  1. 4.1 Tasimelteon Type Introduction
  2. 4.1.1 Original Drug
  3. 4.1.2 Generic Drug
  4. 4.2 Global Tasimelteon Sales Volume by Type
  5. 4.2.1 Global Tasimelteon Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Tasimelteon Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Tasimelteon Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Tasimelteon Sales Value by Type
  9. 4.3.1 Global Tasimelteon Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Tasimelteon Sales Value by Type (2021-2032)
  11. 4.3.3 Global Tasimelteon Sales Value Share by Type (2021-2032)
5 Tasimelteon Market by Application
  1. 5.1 Tasimelteon Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Tasimelteon Sales Volume by Application
  6. 5.2.1 Global Tasimelteon Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Tasimelteon Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Tasimelteon Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Tasimelteon Sales Value by Application
  10. 5.3.1 Global Tasimelteon Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Tasimelteon Sales Value by Application (2021-2032)
  12. 5.3.3 Global Tasimelteon Sales Value Share by Application (2021-2032)
6 Tasimelteon Regional Sales and Value Analysis
  1. 6.1 Global Tasimelteon Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tasimelteon Sales by Region (2021-2032)
  3. 6.2.1 Global Tasimelteon Sales by Region: 2021-2026
  4. 6.2.2 Global Tasimelteon Sales by Region (2027-2032)
  5. 6.3 Global Tasimelteon Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Tasimelteon Sales Value by Region (2021-2032)
  7. 6.4.1 Global Tasimelteon Sales Value by Region: 2021-2026
  8. 6.4.2 Global Tasimelteon Sales Value by Region (2027-2032)
  9. 6.5 Global Tasimelteon Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Tasimelteon Sales Value (2021-2032)
  12. 6.6.2 North America Tasimelteon Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Tasimelteon Sales Value (2021-2032)
  15. 6.7.2 Europe Tasimelteon Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Tasimelteon Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Tasimelteon Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Tasimelteon Sales Value (2021-2032)
  21. 6.9.2 South America Tasimelteon Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Tasimelteon Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Tasimelteon Sales Value Share by Country, 2025 VS 2032
7 Tasimelteon Country-level Sales and Value Analysis
  1. 7.1 Global Tasimelteon Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Tasimelteon Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Tasimelteon Sales by Country (2021-2032)
  4. 7.3.1 Global Tasimelteon Sales by Country (2021-2026)
  5. 7.3.2 Global Tasimelteon Sales by Country (2027-2032)
  6. 7.4 Global Tasimelteon Sales Value by Country (2021-2032)
  7. 7.4.1 Global Tasimelteon Sales Value by Country (2021-2026)
  8. 7.4.2 Global Tasimelteon Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Tasimelteon Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Tasimelteon Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Tasimelteon Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Tasimelteon Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Tasimelteon Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Tasimelteon Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Tasimelteon Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Tasimelteon Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Tasimelteon Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Tasimelteon Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Tasimelteon Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Tasimelteon Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Tasimelteon Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Tasimelteon Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Tasimelteon Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Tasimelteon Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Tasimelteon Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Tasimelteon Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Tasimelteon Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Tasimelteon Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Tasimelteon Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Tasimelteon Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Tasimelteon Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Tasimelteon Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Tasimelteon Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Tasimelteon Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Tasimelteon Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Tasimelteon Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Tasimelteon Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Tasimelteon Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Tasimelteon Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Tasimelteon Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Tasimelteon Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Tasimelteon Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Tasimelteon Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Tasimelteon Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Tasimelteon Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Tasimelteon Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Tasimelteon Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Tasimelteon Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Tasimelteon Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Tasimelteon Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Tasimelteon Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Tasimelteon Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Tasimelteon Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Tasimelteon Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Tasimelteon Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Tasimelteon Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Tasimelteon Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Tasimelteon Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Tasimelteon Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Tasimelteon Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Tasimelteon Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Tasimelteon Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Tasimelteon Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Tasimelteon Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Tasimelteon Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Tasimelteon Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Tasimelteon Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Tasimelteon Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Tasimelteon Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Tasimelteon Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Tasimelteon Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Tasimelteon Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Tasimelteon Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Tasimelteon Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Tasimelteon Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Tasimelteon Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Tasimelteon Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Tasimelteon Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Tasimelteon Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Tasimelteon Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Tasimelteon Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Tasimelteon Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Tasimelteon Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Tasimelteon Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Tasimelteon Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Tasimelteon Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Tasimelteon Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Tasimelteon Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Tasimelteon Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Tasimelteon Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Tasimelteon Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Tasimelteon Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Vanda Pharmaceuticals
  2. 8.1.1 Vanda Pharmaceuticals Company Information
  3. 8.1.2 Vanda Pharmaceuticals Business Overview
  4. 8.1.3 Vanda Pharmaceuticals Tasimelteon Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Vanda Pharmaceuticals Tasimelteon Product Portfolio
  6. 8.1.5 Vanda Pharmaceuticals Recent Developments
  7. 8.2 Teva Pharmaceuticals
  8. 8.2.1 Teva Pharmaceuticals Company Information
  9. 8.2.2 Teva Pharmaceuticals Business Overview
  10. 8.2.3 Teva Pharmaceuticals Tasimelteon Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Teva Pharmaceuticals Tasimelteon Product Portfolio
  12. 8.2.5 Teva Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Tasimelteon Value Chain Analysis
  2. 9.1.1 Tasimelteon Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Tasimelteon Sales Mode & Process
  6. 9.2 Tasimelteon Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Tasimelteon Distributors
  9. 9.2.3 Tasimelteon Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst